Ring Relief Tablet, Orally Disintegrating
FDA Label NDC 17312-023

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Trp Company for the product Ring Relief (NDC 17312-023). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - pregnancy or breast feeding, otc - keep out of reach of children, otc - stop use, dosage & administration, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Pregnancy Or Breast Feeding

If pregnant or breast-feeding, ask a health professional before use.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children

Other

Other information

  • There are no known contraindications.
  • Active ingredients are micro-diluted in accordance with the Homeopathic Pharmacopoeia of the United States and are therefore non-toxic with no known side effects.
  • Store in a cool dark location.
  • Ring Relief Fast Disolving Tablets are homeopathic dilutions: see www.thereliefproducts.com for details.

Inactive Ingredient

Inactive Ingredients
Advantol® 300, Lactose, Magnesium Stearate, Mannitol, Microcrystalline Cellulose.

Otc - Questions

Questions or comments? 888-969-6855
www.thereliefproducts.com

* Please review the disclaimer below.